Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy

Status

Terminated

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00083434

Enrollment

Unknown

Registered

2004-05-26

Start date

2004-02-29

Completion date

2004-10-31

Last updated

2011-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Cancer

Keywords

Anemia, Cancer

Brief summary

The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia in patients who have cancer or who no longer have any signs of the cancer, but remain anemic as a result of their treatment.

Interventions

DRUGEpoetin alfa

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years of age or older * Body weight \>/= 99lbs * ECOG 0-2 * Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy * Screening hemoglobin level of \</= 11.0 g/dL for men or \</= 10.0 for women

Exclusion criteria

* History of or concurrent second malignancy * Evidence of primary or metastatic malignancy involving the Central Nervous System

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026